<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Paper And Industrial essayManaging</title>
	<atom:link href="http://www.perilip.org/tag/managing/feed" rel="self" type="application/rss+xml" />
	<link>http://www.perilip.org</link>
	<description>About  paper and industrial essay Share ideas</description>
	<lastBuildDate>Sat, 09 Jan 2010 19:11:24 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Managing Innovation and Change: Case of Pharmaceutical Industry</title>
		<link>http://www.perilip.org/managing-innovation-and-change-case-of-pharmaceutical-industry</link>
		<comments>http://www.perilip.org/managing-innovation-and-change-case-of-pharmaceutical-industry#comments</comments>
		<pubDate>Wed, 02 Dec 2009 11:02:59 +0000</pubDate>
		<dc:creator></dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[Case]]></category>
		<category><![CDATA[Change]]></category>
		<category><![CDATA[Industry]]></category>
		<category><![CDATA[Innovation]]></category>
		<category><![CDATA[Managing]]></category>
		<category><![CDATA[Pharmaceutical]]></category>

		<guid isPermaLink="false">http://www.perilip.org/managing-innovation-and-change-case-of-pharmaceutical-industry</guid>
		<description><![CDATA[<p>In contemporary context, the pharmaceutical and biotechnology sectors are characterised by a high level of competition and innovation. Some fifteen or twenty years ago biotechnology, which was heavily depended on advances in molecular biology, and pharmaceuticals, which was predominantly based on microbiology and chemistry, were widely recognized as separate industries. However, now biotechnology and pharmaceutical companies are significantly interconnected and are evolving into complex systems, representing particular innovation networks.
The transformation from an old to a new <a href='http://www.perilip.org/managing-innovation-and-change-case-of-pharmaceutical-industry' rel="nofollow">Read more</a></p>Here is no comments yet by the time your rss reader get this, Do you want to be the first commentor? Hurry up]]></description>
			<content:encoded><![CDATA[<p>In contemporary context, the pharmaceutical and biotechnology sectors are characterised by a high level of competition and innovation. Some fifteen or twenty years ago biotechnology, which was heavily depended on advances in molecular biology, and pharmaceuticals, which was predominantly based on microbiology and chemistry, were widely recognized as separate industries. However, now biotechnology and pharmaceutical companies are significantly interconnected and are evolving into complex systems, representing particular innovation networks.
The transformation from an old to a new <a href='http://www.perilip.org/managing-innovation-and-change-case-of-pharmaceutical-industry' rel="nofollow">Read more</a></p>Here is no comments yet by the time  your rss reader get this, Do you want to be the first commentor? Hurry up ]]></content:encoded>
			<wfw:commentRss>http://www.perilip.org/managing-innovation-and-change-case-of-pharmaceutical-industry/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

